Osteogenesis imperfecta: Effect of magnesium administration on pyrophosphate metabolism
β Scribed by C. C. Solomons; J. Styner
- Publisher
- Springer
- Year
- 1969
- Tongue
- English
- Weight
- 905 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Sintered dicalcium pyrophosphate (SDCP), a synthetic compound, has proved to be both bioabsorbable and biocompatible __in vivo__. Recent work in our institute also has demonstrated that the ingestion of SDCP can increase bone mass in the ovariectomized rat. In this study, we used an __i
## Abstract Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RAN
## Abstract We studied the influence of transforming growth factor beta (TGFβΞ²) on cultured bone cells derived from two patients with osteogenesis imperfecta (OI) and from human controls. Additionally, cells from a hyperplastic callus that had developed spontaneously at the femur of the patient in